Market Tracker

07/27 5:16pm ET

Repligen Corp (NASDAQ:RGEN)

28.31
Delayed Data
As of Jul 27
 +0.83 / +3.02%
Today’s Change
20.07
Today|||52-Week Range
39.17
+0.07%
Year-to-Date
No recent news for Repligen Corp.

Today’s Trading

Previous close27.48
Today’s open27.53
Day’s range27.50 - 28.33
Volume211,726
Average volume (3 months)294,960
Market cap$924.4M
Dividend yield--
Data as of 3:59pm ET, 07/27/2016

Growth & Valuation

Earnings growth (last year)+12.00%
Earnings growth (this year)+67.86%
Earnings growth (next 5 years)+25.00%
Revenue growth (last year)+31.45%
P/E ratio118.0
Price/Sales11.37
Price/Book7.38

Competitors

 Today’s
change
Today’s
% change
ADROAduro Biotech Inc+0.67+4.70%
FWPForward Pharma A/S-0.11-0.55%
CXRXConcordia Internatio...-0.16-0.87%
CLLSCellectis SA+0.62+2.44%
Data as of 3:59pm ET, 07/27/2016

Financials

Next reporting dateAugust 4, 2016
EPS forecast (this quarter)$0.13
Annual revenue (last year)$83.5M
Annual profit (last year)$9.3M
Net profit margin11.19%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Tony J. Hunt
Vice President-
Global Operations
Steve Curran
Corporate headquarters
Waltham, Massachusetts

Forecasts